Context Therapeutics, Inc. (CNTX)
0.1891
-0.01
(-6.25%)
USD |
NASDAQ |
Oct 30, 16:00
0.1905
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Market Cap : 17.37M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 17.37M |
| October 29, 2026 | 18.53M |
| October 28, 2026 | 19.41M |
| October 27, 2026 | 21.56M |
| October 26, 2026 | 22.04M |
| October 23, 2026 | 21.99M |
| October 22, 2026 | 21.65M |
| October 21, 2026 | 21.26M |
| October 20, 2026 | 22.40M |
| October 19, 2026 | 21.90M |
| October 16, 2026 | 22.42M |
| October 15, 2026 | 22.10M |
| October 14, 2026 | 23.48M |
| October 13, 2026 | 25.27M |
| October 12, 2026 | 28.02M |
| October 09, 2026 | 27.95M |
| October 08, 2026 | 27.47M |
| October 07, 2026 | 28.72M |
| October 06, 2026 | 29.57M |
| October 05, 2026 | 30.92M |
| October 02, 2026 | 28.46M |
| October 01, 2026 | 28.89M |
| September 30, 2026 | 27.60M |
| September 29, 2026 | 29.31M |
| September 28, 2026 | 29.98M |
| Date | Value |
|---|---|
| September 25, 2026 | 31.76M |
| September 24, 2026 | 34.10M |
| September 23, 2026 | 35.15M |
| September 22, 2026 | 35.75M |
| September 21, 2026 | 34.42M |
| September 18, 2026 | 33.82M |
| September 17, 2026 | 35.23M |
| September 16, 2026 | 34.82M |
| September 15, 2026 | 33.48M |
| September 14, 2026 | 32.25M |
| September 11, 2026 | 32.19M |
| September 10, 2026 | 33.66M |
| September 09, 2026 | 34.00M |
| September 08, 2026 | 34.57M |
| September 04, 2026 | 33.23M |
| September 03, 2026 | 33.35M |
| September 02, 2026 | 33.32M |
| September 01, 2026 | 33.47M |
| August 31, 2026 | 35.81M |
| August 28, 2026 | 35.25M |
| August 27, 2026 | 38.23M |
| August 26, 2026 | 38.93M |
| August 25, 2026 | 40.00M |
| August 24, 2026 | 42.76M |
| August 21, 2026 | 45.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 369.11B |
| EyePoint, Inc. | 29.61M |
| Neumora Therapeutics, Inc. | 68.61M |
| LENZ Therapeutics, Inc. | 95.82M |
| ANI Pharmaceuticals, Inc. | 1.654B |
Market Cap Related Metrics
| PEG Ratio | -0.0165 |
| Price to Book Value | 0.4552 |
| Price | 0.1891 |
| Earnings Yield | -258.0% |
| PEGY Ratio | -0.0165 |